Grey Wolf Therapeutics
Clinical trials sponsored by Grey Wolf Therapeutics, explained in plain language.
-
New pill aims to tame back inflammation in axial spondyloarthritis
Disease control Recruiting nowThis study tests an experimental oral drug called GRWD0715 for axial spondyloarthritis, a chronic inflammatory condition affecting the spine and pelvis. The trial starts with healthy volunteers to check safety, then moves to patients to see if the drug reduces inflammation and im…
Phase: PHASE1, PHASE2 • Sponsor: Grey Wolf Therapeutics • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New pill shows promise in early cancer trial
Disease control Recruiting nowThis study tests an experimental drug called GRWD5769, taken as a pill, for people with advanced solid tumors that have not responded to standard treatments. The trial has two phases: first, to check safety and find the right dose, and second, to see if the drug shrinks tumors wh…
Phase: PHASE1, PHASE2 • Sponsor: Grey Wolf Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC